Cooperative Agreement NU62PS924777

Award Date 1/1/22
Completion Date 12/31/26
Dollars Obligated $7.2M
Funding Federal Agency
National Center for HIV/AIDS
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.944
Assistance Type
Cooperative Agreement
Place of Performance
Pennsylvania, USA
Similar Awards
This Cooperative Agreement award from the National Center for HIV/AIDS, part of the Centers for Disease Control and Prevention (CDC), provides $742,220 in funding to the Massachusetts Department of Public Health (MDPH) to support the Massachusetts STI Surveillance Network. The goals of this 5-year project are to: (1) expand and improve STI surveillance data to develop a stronger knowledge base of STI trends and social determinants; (2) guide the development of tailored, evidence-based public...
The Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC) awarded a 5-year, $46,921,723 Cooperative Agreement to Health Research, Inc.'s Aids Institute Division under CFDA 93.939 - HIV Prevention Activities Non-Governmental Organization Based program. The award will support a comprehensive HIV prevention and surveillance program in New York, which aims to increase knowledge of HIV status, reduce HIV transmission, prevent new infections, improve linkage...
The City of New York Department of Health and Mental Hygiene was awarded a $260,740 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The award will fund a 5-year project (9/30/2024 - 9/29/2029) to strengthen sexually transmitted infection (STI) surveillance in New York City. Key activities include implementing protocol-based sentinel and enhanced surveillance in sexual health...
The New Hampshire Department of Health & Human Services (NH DHHS) received a $4,617,629 Cooperative Agreement award from the National Center for HIV/AIDS under the HIV Prevention Activities Non-Governmental Organization Based Federal Grant Program (CFDA 93.939). The award, with a performance period from August 1, 2024 to May 31, 2029, will fund comprehensive and integrated HIV surveillance and prevention activities in New Hampshire. This includes achieving and sustaining viral suppression,...
The Baltimore City Health Department (BCHD) was awarded a $731,482 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Sexually Transmitted Diseases (STD) Prevention and Control Grants program (CFDA 93.977). The 5-year award, effective September 30, 2024, will support BCHD's commitment to obtaining high-quality sentinel and enhanced case-based STI/HIV surveillance data to advance data-driven strategies for improving clinical services and prevention. Key...
The Hawaii Department of Health (HDOH) was awarded a $2,972,090 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939). The funding will support HDOH's efforts to improve Hawaii's HIV prevention and surveillance system through strategies to: 1) increase HIV status knowledge to 95%, 2) rapidly link individuals to HIV care and achieve 95% viral suppression, 3) expand PrEP and...
This Cooperative Agreement award from the National Center for HIV/AIDS at the Centers for Disease Control and Prevention (CDC) under CFDA 93.940 - HIV Prevention Activities Health Department Based provides $34,362,657 to the Massachusetts Department of Public Health (MDPH) to implement high-impact HIV prevention, surveillance, and health equity strategies across the Commonwealth. The key products and services to be delivered through this 5-year award include: increasing HIV testing and linkage...
The Baltimore City Health Department (BCHD) was awarded a $1,800,000 cooperative agreement by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The funding will support BCHD's Sexual Health and Wellness Clinics (SHWCs) in delivering a range of HIV prevention and sexual health services over a 5-year period from August 2024 to July 2029. Key activities include: Building capacity to provide immunizations for...
This $2,400,000 Cooperative Agreement awarded by the National Center for HIV/AIDS under the HIV Prevention Activities Health Department Based program (CFDA 93.940) will support and scale up HIV prevention services at Public Health - Seattle & King County's Sexual Health Clinic. The funding will strengthen the clinic's infrastructure and improve service delivery to address the syndemic of HIV and other sexually transmitted infections, with a focus on two priority populations: men who have sex...
The U.S. Department of Health & Human Services, through its National Center for HIV/AIDS, awarded a $129,005,015 Cooperative Agreement to the New York City Department of Health and Mental Hygiene (Health Dept) under the HIV Prevention Activities Health Department Based (CFDA 93.940) program. This 5-year grant, effective August 1, 2024, will support the Health Dept's comprehensive and integrated HIV surveillance and prevention program to achieve the national Ending the HIV Epidemic (EHE) goal...

TO CONTINUE AN ONGOING BIO-BEHAVIORAL SURVEILLANCE SYSTEM TO MONITOR THE HIV EPIDEMIC AMONG HIGH-RISK POPULATIONS, INCLUDING MSM, IDU AND HETEROSEXUALS. - THE PURPOSE OF THE NATIONAL HIV BEHAVIORAL SURVEILLANCE PROGRAM IS TO MONITOR THE HIV EPIDEMIC THROUGH HIV BEHAVIORAL SURVEILLANCE. THE OBJECTIVES OF THIS PROGRAM ARE TO MAINTAIN AN ONGOING SURVEILLANCE SYSTEM TO ASCERTAIN THE PREVALENCE OF HIV RISK BEHAVIORS AND HIV INFECTION AMONG GROUPS AT HIGH RISK FOR ACQUIRING HIV INFECTION AND TO USE THIS DATA IN DEVELOPING AND DIRECTING BOTH LOCAL AND NATIONAL PREVENTION SERVICES AND PROGRAMS. DATA COLLECTION WILL ROTATE EACH YEAR AMONG MEN WHO HAVE SEX WITH MEN (MSM), INJECTING DRUG USERS (IDU), AND HETEROSEXUALS AT INCREASED RISK FOR HIV INFECTION. NHBS IS AN ANONYMOUS, CROSS-SECTIONAL, MULTI-SITE SURVEY THAT UTILIZES A STANDARDIZED QUESTIONNAIRE. SAMPLING AND RECRUITMENT STRATEGIES WILL INCLUDE VENUE BASED, TIME-SPACE SAMPLING AND RESPONDENT DRIVEN SAMPLING SURVEYS. A MINIMUM OF 500 ELIGIBLE PARTICIPANTS EACH YEAR/RISK GROUP WILL BE ENROLLED. THIS SYSTEM WILL ASSESS RISK BEHAVIORS AND ACCESS TO AND UTILIZATION OF HIV PREVENTION PROGRAMS INCLUDING PREP. VOLUNTARY TESTING FOR HIV INFECTION WILL BE CONDUCTED IN ORDER TO ASSESS HIV SEROPREVALENCE AND INCIDENCE. IN ADDITION, HEPATITIS TESTING WILL BE OFFERED DURING THE IDU CYCLE IN ORDER TO MEASURE THE HBV AND HCV IS THIS POPULATION. TRANSGENDER HIV BEHAVIORAL SURVEILLANCE (THBS) WILL ALSO BE IMPLEMENTED TO STRENGTHEN THE NATIONAL CAPACITY TO MONITOR THE HIV EPIDEMIC AND IMPROVE THE DIRECTION AND EVALUATION OF PREVENTION EFFORTS AMONG MALE-TO-FEMALE TRANSGENDER PERSONS. THE THBS DATA WILL ALSO SERVE TO MEET THE CDC HIV PREVENTION STRATEGIC PLAN OBJECTIVE OF IMPROVING SURVEILLANCE OF HIV-RELATED RISK BEHAVIORS AMONG TRANSGENDER OR GENDER VARIANT PERSONS. THIS PROGRAM WILL PROVIDE AN OPPORTUNITY TO CAPITALIZE ON EXPERIENCE RECRUITING AT-RISK INDIVIDUALS FROM NON-HEALTH CARE COMMUNITY SETTINGS USING SCIENTIFICALLY SOUND METHODOLOGIES TO MAINTAIN AN ONGOING SYSTEM FOR SURVEILLANCE OF BEHAVIORS RELATED TO HIV ACQUISITION. THIS WILL STRENGTHEN THE CAPACITY NATIONWIDE TO MONITOR THE HIV/AIDS EPIDEMIC, DEVELOP AND IMPLEMENT EFFECTIVE HIV PREVENTION INTERVENTIONS AND EVALUATE PREVENTION PROGRAMS.

Posted 12/16/21, 12:00 AM